173
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?

&
Pages 2467-2476 | Accepted 28 Jun 2007, Published online: 30 Aug 2007

References

  • Mossialos E, Dixon A, Figueras J, Kutzin J (eds.). Funding Health Care: Options for Europe. European Observatory on Health Care Systems. Buckingham: Open University Press, 2002
  • Simoens S, De Coster S. Sustaining Generic Medicines Markets in Europe. Research Centre for Pharmaceutical Care and Pharmaco-Economics, Catholic University of Leuven, 2006
  • Sandier S, Paris V, Polton D. Health care systems in transition: France. European Observatory on Health Systems and Policies, 2004. Available from: www.euro.who.int/document/e83126.pdf [Last accessed 8 November 2006]
  • Kanavos P, Gemmill MG. Pharmaceutical Pricing and Reimbursement in Europe. London: Informa Publishing, 2005
  • Le Pen, C. Drug pricing and reimbursement in France. Pharmaco-economics 1996;10(Suppl. 2):26–36
  • Le Pen C. Substitution générique et prescription dans le répertoire (Generic substitution and prescribing practices in the off-patent market). University of Paris-Dauphine: Paris, 2005
  • Comité économique des produits de santé (CEPS). Accord cadre entre le Comité économique des produits de santé et les entreprises du médicament pour la période 2003–2006. Available from: www.sante.gouv.fr/htm/dossiers/accord_med/contenu.htm [Last accessed 8 November 2006]
  • Le Monde. Les pharmaciens, cible de choix des laboratoires’. Paris, 31 October, 2003
  • Kanavos P. Do generics offer significant savings to the UK NHS? Curr Med Res Opin 2006;23:105–16
  • Caves RE, Whinston ME, Hurwitz MA. Patent expiration, entry and competition in the United States pharmaceutical industry: an exploratory analysis. Brookings Papers on Economic Activity: Microeconomics 1991. Washington: Brookings Institute, 1991:1–48
  • Grabowski H, Vernon J. Brand loyalty and price competition in pharmaceuticals after the 1984 Drug Act’, Journal of Law and Economics 1992;35: 331–50
  • Garattini L, Ghislandi S. Off-patent drugs in Italy. A short sighted view? Eur J Health Econ 2006;7:79–83
  • Ricketts M. The economics of business enterprise: New approaches to the firm. Brighton: Wheatsheaf Books, 1987
  • Direction de la Recherche des Etudes de l’Evaluation et des Statistiques (DREES). Les Pharmaciens en France. Situation démographique et trajectoires professionnelles. Études et Résultats, Numéro 437, Octobre. Paris: Ministère de la Santé et des Solidarités, 2005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.